Skip to main content

Together we are beating cancer

Donate now

Hormone therapy

Showing 11 out of 35 results
Cancer Research UK logo

Experts are urging breast cancer patients to complete their full prescription of tamoxifen, following long-term results from a major Cancer Research UK-funded trial which showed the cancer was less likely to come back in women who took the drug for five years, compared to two years. Experts are urging breast cancer patients to complete their full prescription of tamoxifen, following long-term results from a major Cancer Research UK-funded trial which showed the cancer was less likely to come back in women who took the drug for five years, compared to two years.

by Cancer Research UK | News | 21 March 2011

21 March 2011

Cancer Research UK logo

A major international trial has confirmed the long-term benefit of anastrozole to help stop breast cancer coming back or developing in the other breast in postmenopausal women with hormone sensitive early breast cancer, according to a study published in Lancet Oncology today (Wednesday). A major international trial has confirmed the long-term benefit of anastrozole to help stop breast cancer coming back or developing in the other breast in postmenopausal women with hormone sensitive early breast cancer, according to a study published in Lancet Oncology today (Wednesday).

by Cancer Research UK | News | 1 December 2010

1 December 2010

Cancer Research UK logo

MEN TREATED with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool MEN TREATED with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool

by The National Cancer Research Institute (NCRI) | News | 8 November 2010

8 November 2010

Cancer Research UK logo

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology. Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

by Cancer Research UK | News | 20 July 2010

20 July 2010

Cancer Research UK logo
  • Science & Technology
  • Health & Medicine

Scientists unlock key to tamoxifen resistance

Cancer Research UK funded scientists have discovered why some breast cancers are resistant to the commonly used drug tamoxifen, their findings are published in Cancer Research. Cancer Research UK funded scientists have discovered why some breast cancers are resistant to the commonly used drug tamoxifen, their findings are published in Cancer Research.

by Cancer Research UK | News | 23 February 2010

23 February 2010

Cancer Research UK logo

The largest clinical trial of its kind - which aims to find out if testing breast cancer cells after two weeks of hormone therapy can help predict how well a woman will respond to treatment - is being outlined at the NCRI Cancer Conference. The largest clinical trial of its kind - which aims to find out if testing breast cancer cells after two weeks of hormone therapy can help predict how well a woman will respond to treatment - is being outlined at the NCRI Cancer Conference.

6 October 2009

Cancer Research UK logo

Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet. Women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease, according to a study published in the Lancet.

by Cancer Research UK | News | 19 April 2007

19 April 2007

Cancer Research UK logo

Some forms of hormone replacement therapy increase the risk of endometrial (womb) cancer, according to results from the Million Women Study, published in the Lancet1today. Some forms of hormone replacement therapy increase the risk of endometrial (womb) cancer, according to results from the Million Women Study, published in the Lancet1today.

by Cancer Research UK | News | 28 April 2005

28 April 2005

Cancer Research UK logo

Some kinds of hormone replacement therapy (HRT) have a much greater effect on a woman's risk of breast cancer than others, according to landmark research published in the Lancet. Some kinds of hormone replacement therapy (HRT) have a much greater effect on a woman's risk of breast cancer than others, according to landmark research published in the Lancet.

by Cancer Research UK | News | 7 August 2003

7 August 2003

Cancer Research UK logo
  • Health & Medicine

Why women take HRT

A woman's medical history has a greater influence over whether she takes hormone replacement therapy than lifestyle factors or social background, according to a report1 published today. A woman's medical history has a greater influence over whether she takes hormone replacement therapy than lifestyle factors or social background, according to a report1 published today.

by Cancer Research UK | News | 11 December 2002

11 December 2002

Cancer Research UK logo
  • Health & Medicine

What women on HRT need to know

The long term effects of Hormone Replacement Therapy significantly increase the risk of breast cancer and stroke according to Cancer Research UK scientists in a report1 published today. The long term effects of Hormone Replacement Therapy significantly increase the risk of breast cancer and stroke according to Cancer Research UK scientists in a report1 published today.

by Cancer Research UK | News | 19 September 2002

19 September 2002